Diagnostic and Prognostic Models

106 Items

All Items

Role of telomere maintenance genes as a predictive biomarker for colorectal cancer immunotherapy response and prognosis

Zhikai Wang, Chunyan Zhao, Yifen Huang, Chong Li

2696–2711
- PDF
Risk and prognosis of second cutaneous melanoma after radiotherapy for breast cancer: A population-based analysis

Tianxin Luo, Yani Zhang, Tianliang Chen, Yanxia Cai, Zheng Yang

959-967
Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy: A review

Marek Zdrenka, Adam Kowalewski, Navid Ahmadi, Rizwan Ullah Sadiqi, Łukasz Chmura, Jędrzej Borowczak, Mateusz Maniewski, Łukasz Szylberg

14–29
- PDF
- XML
Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy

Xiaojun Zhang, Mengxuan Gu, Jiahao Zhu, Ruike Gu, Bo Yang, Shengjun Ji, Yutian Zhao, Ke Gu

986–999
- PDF
Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP

Hui Su, Chao Yu, Guiming Sun, Baozhong Wang, Yingjie Gao, Xiaolan Liu, Qingcui Song, Xuezhen Ma

29–41
- PDF
Prognostic significance and immunological role of HPRT1 in human cancers

Yiwen Lu, Ruixue Chen, Han Zhang, Xu Sun, Xiangjun Li, Mengyuan Yang, Xudong Zhang

262–291
- PDF
Prognostic impact of pan-immune inflammation value in small-cell lung cancer treated with chemoradiotherapy and prophylactic cranial irradiation

Aybala Nur Ucgul, Huseyin Hazir, Huseyin Bora

2658–2665
- PDF
$Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study$

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

Sabin Goktas Aydin, Engin Eren Kavak, Atakan Topcu, Ayberk Bayramgil, Fahri Akgul, Seda Kahraman, Musa Baris Aykan, Yunus Emre Altıntas, Kaan Helvaci, Yuksel Urun, Ahmet Bilici, Mesut Seker, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Ozgur Acikgoz, Irfan Cicin

1089–1095
- XML
- PDF
Prognostic evaluation in gallbladder carcinoma: Introducing a composite risk model integrating nutritional and immune markers

Si-qi Yang, Rui-qi Zou, Yu-shi Dai, Hai-jie Hu, Fu-yu Li

425–435
- PDF
Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

Marija Kraljević, Inga Marijanović, Maja Barbarić, Emir Sokolović, Merima Bukva, Timur Cerić, Teo Buhovac

161-169
- XML
- PDF
Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome

Bedrettin Orhan, Hülya Öztürk Nazlıoğlu, Oğuzhan Dik, Büşra Gürbüz, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar, Cumali Yalçın, Sinem Çubukçu, Tuba Güllü Koca, Fazıl Çağrı Hunutlu, Şeyma Yavuz, Rıdvan Ali, Fahir Özkalemkaş

1175–1183
- PDF
Predictive and prognostic value of preoperative pan-immune-inflammation value in patients with locally advanced rectal cancer

Peipei Shen, Yu Xu, Jiahao Zhu, Danqi Qian, Bo Yang, Yong Mao, Shengjun Ji, Ke Gu, Yutian Zhao

1000–1008
Prediction of post-insertion infections related to totally implantable subcutaneous venous access ports in tumor patients using a nomogram

Sen Wang, Heng Zong, Lei Tang, Yuandong Wei

1601–1609
- PDF
Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study

Jifeng Feng, Liang Wang, Xun Yang, Qixun Chen, Xiangdong Cheng

153-160
- PDF
- XML
Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index

Nulifer Kilic Durankus, Efsun Somay, Sibel Bascil, Sukran Senyurek, Duriye Ozturk, Ugur Selek, Erkan Topkan

240–248
- PDF
PD-L1 testing by immunohistochemistry in immuno-oncology

Semir Vranic, Zoran Gatalica

15-25
- PDF
- XML
Parathyroid hormone-related protein as a potential prostate cancer biomarker: Promoting prostate cancer progression through upregulation of c-Met expression

Yan Zhao, Zhen-Yu Fu, Han-Yong Feng, Yu-Hao Peng, Zhi-Xiang Yin, Jing-Yi Cao, Chang-Song Pei

374–386
- PDF
Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis

Xuemin Zeng, Dapeng Ren, Ran Liu, Qiang Zhang, Xiao Yan, Xiao Yuan

952-958
- PDF
OncoImmune machine-learning model predicts immune response and prognosis in leiomyosarcoma

Jingrong Deng, Changfa Shu, Dong Wang, Richard Nimbona, Xingping Zhao, Dabao Xu

2308–2323
Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

Zhenchi Li, Zhibin Xu, Jiangping Wang, Mei Wang

633–646
- PDF

Previous 21-40 of 106 Next

Diagnostic and Prognostic Models

All Items

Role of telomere maintenance genes as a predictive biomarker for colorectal cancer immunotherapy response and prognosis

Risk and prognosis of second cutaneous melanoma after radiotherapy for breast cancer: A population-based analysis

Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy: A review

Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy

Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP

Prognostic significance and immunological role of HPRT1 in human cancers

Prognostic impact of pan-immune inflammation value in small-cell lung cancer treated with chemoradiotherapy and prophylactic cranial irradiation

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

Prognostic evaluation in gallbladder carcinoma: Introducing a composite risk model integrating nutritional and immune markers

Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome

Predictive and prognostic value of preoperative pan-immune-inflammation value in patients with locally advanced rectal cancer

Prediction of post-insertion infections related to totally implantable subcutaneous venous access ports in tumor patients using a nomogram

Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study

Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index

PD-L1 testing by immunohistochemistry in immuno-oncology

Parathyroid hormone-related protein as a potential prostate cancer biomarker: Promoting prostate cancer progression through upregulation of c-Met expression

Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis

OncoImmune machine-learning model predicts immune response and prognosis in leiomyosarcoma

Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

impact_factor_6

Sidebar_menu